(Q46888688)

English

Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats

scientific article published in November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

author name string

Janet M Ledingham

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

Richard Laverty

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

32

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

919-925

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Fluvastatin remodels resistance arteries in genetically hypertensive rats, even in the absence of any effect on blood pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Histology of subcutaneous small arteries from patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04285.X

21 January 2018

Identifiers

10.1111/J.1440-1681.2005.04285.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

release_kswqjzaqardpxe6nk6mstx7n6a

1 reference

https://api.fatcat.wiki/v0/release/kswqjzaqardpxe6nk6mstx7n6a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16405447

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46888688&oldid=2136279487"